Is NRIX overvalued right now?
Based on our 2026 models, Nurix Therapeutics, Inc. (NRIX) appears overvalued at $26.95 with roughly 47.3% downside versus fair value. Confirm with valuation ratios and financials before acting.
Nurix Therapeutics, Inc. (NRIX) is currently Overvalued by 47.33%
Instant valuation answer
Nurix Therapeutics, Inc. (NRIX) appears overvalued by approximately 47.33% based on our live valuation percent and intrinsic value estimate derived from DCF, P/E Multiple, and P/S Multiple models. Valuation can still differ across analyst models, growth expectations, and risk assumptions.
- Downside (live) 47.33% (from live valuation API)
- Confidence (live) 8.5/10 (High conviction overvalued)
Confidence Score is based on the magnitude of upside or downside vs intrinsic value.
Fair value estimate
Unlock fair valueCurrent price
$26.95
Explore Our Valuation Calculators
Why is Nurix Therapeutics, Inc. overvalued or undervalued?
Intrinsic value work anchors Nurix Therapeutics, Inc. on owner earnings and balance-sheet capacity; the current quote trades above that anchor, which frames the stock as relatively rich on a fundamentals-first view.
Versus historical valuation bands, NRIX is closer to the upper end of where this business has traded when profitability and growth were comparable—useful context before reading any single headline multiple.
Forward market expectations are elevated: the price requires heroic assumptions to converge with our fair-value zone, but sector peers and macro rates still deserve a quick sanity check on the company page.
Key metrics
- P/E ratio
- 33.6x
- Revenue growth (TTM y/y)
- 26%
- Profit margin
- 26.1%
- Fair value (model)
- Unlock
Frequently asked questions — NRIX
What is Nurix Therapeutics, Inc.'s intrinsic value?
Our DCF, P/E Multiple, and P/S Multiple models estimate whether NRIX trades above or below fair value. At $26.95, Nurix Therapeutics, Inc. currently looks overvalued on this snapshot. Tickerplace Pro unlocks the full dollar fair value estimate.
How is Nurix Therapeutics, Inc.'s intrinsic value calculated?
Tickerplace calculates NRIX's fair value using Discounted Cash Flow (DCF), P/E Multiple, and P/S Multiple models. We compare the resulting intrinsic value estimate to the live market price to flag undervalued or overvalued positioning.
Is NRIX undervalued right now?
A stock is undervalued when price sits below a supportable fair value range. Check whether NRIX's gap aligns with fundamentals using the ratios and financial links on this page.